Bioventus Q1 returns to profit; revenue rises 7% to $132.1 million

Bioventus, Inc. Class A

Bioventus, Inc. Class A

BVS

0.00
  • Bioventus posted Q1 revenue of USD 132.1 million, up 7%, as GAAP earnings swung to USD 0.04 per diluted share from a loss per share a year earlier.
  • Net income attributable to shareholders returned to profit at USD 3.1 million, while cash from operations rose to USD 8.9 million from an outflow in the prior-year period.
  • Adjusted EBITDA climbed 24% to USD 23.9 million, with Pain Treatments revenue up 7.7% to USD 63.4 million on a favorable rebate benefit tied to a billing process change by a US private payer.
  • Guidance for full-year 2026 net sales was reaffirmed at USD 600 million to USD 610 million, while adjusted EPS was raised to USD 0.75 to USD 0.79.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioventus Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605060730PRIMZONEFULLFEED9713855) on May 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.